Table 1.
Baseline characteristics of 28 patients
| n (%) | |
|---|---|
| Age average (range) | 60.5 (33–76) |
| Sex male | 18 (64%) |
| female | 10 (36%) |
| Tumour stage at diagnosis | |
| I | 16 (57%) |
| II | 6 (21%) |
| III | 1 (4%) |
| IV | 5 (18%) |
| Tumour size (mm) average (range) | 35 (5–114) |
| Location | |
| Unilateral | 12 (43%) |
| Bilateral | 16 (57%) |
| Single lesion | 10 (36%) |
| Multiple lesions | 18 (64%) |
| Pleural effusion | 2 (7%) |
| Mosaic pattern | 1 (3%) |
| Lung cysts | 4 (145) |
| Thoracic lymph nodes | 8 (29%) |
| 18F-FDG PET/CT pos | 26 (93%) |
| SUVmax average (range) | 5.3 (1.1–13) |
| lesion-to-liver SUVmax ratio average (range) | 2.3 (0.4–6) |
| lesion-to-blood pool SUVmax ratio average (range) | 2.8 (0.5–8.2) |
CMT, chemotherapy; FDG, fluorodesoxyglucose; Mm, millimeter; Pos, positive; RTT, radiotherapy; SUV, standardized uptake value.